Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis when Adjuvant Mifamurtide is Combined with High-Dose Ifosfamide By Ogkologos - August 28, 2025 146 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ISG/OS-2 and GEIS-33 studies Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Researchers Discover Potential Way to Hit Elusive Target in Pancreatic Cancer April 4, 2019 Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid... August 12, 2025 EMA Recommends Extending Indications for Zanubrutinib to Include Treatment of Patients... November 2, 2023 Boy Born With Heart Defect Gets Surgery To Help It Triple... December 26, 2021 Load more HOT NEWS Study presents an AI-guided approach to target cancer antigens ΝΕΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ Mom Who Lost Child Donates Breast Milk To Mom With Cancer AI and remote monitoring are shaping a new patient journey in...
